FDA approves second West Nile Virus test

Aug 29, 2007

The U.S. Food and Drug Administration has approved a second screening test for West Nile Virus disease for use in donated blood and organs.

The cobas TaqScreen WNV test is an automated test that's able to detect the genetic material of the virus itself early during the infection process, the FDA said. The nucleic acid testing detects whether donated blood and organs have been infected, even if the donor's body hasn't begun to produce antibodies against the virus.

West Nile Virus is most often transmitted to humans by mosquitoes but it can also be transmitted through blood transfusion or organ transplantation from infected donors.

The approval means blood centers and hospitals will have a choice of two FDA-approved tests, said Dr. Jesse Goodman, director of the FDA's Center for Biologics Evaluation and Research.

The newly approved test is manufactured by Roche Molecular Systems Inc. of Pleasanton, Calif.

Copyright 2007 by United Press International

Explore further: NY and NJ say they will require Ebola quarantines

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Two US states order tough Ebola quarantine rules

6 minutes ago

New York and New Jersey on Friday ordered a mandatory quarantine for medics who treated victims of Ebola in West Africa, after the deadly virus spread to America's largest city.

NY and NJ say they will require Ebola quarantines

17 hours ago

The governors of New Jersey and New York on Friday ordered a mandatory, 21-day quarantine for all doctors and other arriving travelers who have had contact with Ebola victims in West Africa.

User comments : 0